Cancer Immune Atlas

Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive signatures.

Cancer Immune Atlas

Cancer Immune Atlas

The Cancer Immune Atlas, powered by our Immunogram program is designed to produce robust statistical analyses across hundreds of patients. This creates a scouting database with state-of-the art bioinformatic tools, including AI. The Atlas provides a variety of readouts and can serve a variety of research initiatives:

  • Generate high-resolution tumor microenvironment biomarker maps
  • Link individual tumor microenvironments and genomic fitness to toxicity and/or drug response
  • Develop predictive signature of response/toxicity to inform patient selection
  • Identify new pathway/targets
  • Guide CDx Development through visualization of key biomarker signatures
ATLAS_200621
Immunogram powering@2x

THE CANCER IMMUNE ATLAS: POWERED BY IMMUNOGRAM

Immunogram is a multi-modal platform to comprehensively understand the intricacies of the tumor immune microenvironment. This unique platform seamlessly integrates multi-omic data sets generated from a variety of genomic, transcriptomic, and proteomic platforms.

This tool allows Veracyte to generate, integrate, analyze, and report complex data sets, ultimately providing an actionable data visualization that highlights key biomarker signatures at the individual patient level.

Immunogram can be adapted and customized to each client’s specific needs and can provide key insights into MoA, biomarker signatures for CDx development, patient stratification, response, and much more.

Related Services

Contact our team to discuss your project